REGENXBIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.44 USD | -1.53% |
|
-8.26% | -13.98% |
| May. 09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
| May. 08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENXBIO INC. | Bio Therapeutic Drugs | -1.53% | -8.26% | -13.98% | -19.58% | -66.29% | 761M |  |  | |
- Stock Market
- Equities
- RGNX Stock
- Charts REGENXBIO Inc.
- Relative Strength Chart